Janus Kinase Inhibitors

Displaying 1 - 4 of 4CSV
Nohria, A., Desai, D., Shapiro, J., Bordone, L., & Lo Sicco, K. (2024). Review of the use of Janus kinase inhibitors in the treatment of scarring alopecia. International Journal of Dermatology, 63(6). Portico. https://doi.org/10.1111/ijd.17153
Publication Date
Son, A., Meylan, F., Gomez-Rodriguez, J., Kaul, Z., Sylvester, M., Falduto, G. H., Vazquez, E., Haque, T., Kitakule, M. M., Wang, C., Manthiram, K., Qi, C.-F., Cheng, J., Gurram, R. K., Zhu, J., Schwartzberg, P., Milner, J. D., Frischmeyer-Guerrerio, P. A., & Schwartz, D. M. (2023). Dynamic chromatin accessibility licenses STAT5- and STAT6-dependent innate-like function of TH9 cells to promote allergic inflammation. Nature Immunology, 24(6), 1036–1048. https://doi.org/10.1038/s41590-023-01501-5
Publication Date
Dai, Z., Sezin, T., Chang, Y., Lee, E. Y., Wang, E. H. C., & Christiano, A. M. (2022). Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.955038
Publication Date